NCT00525473View on ClinicalTrials.gov

Correlation of Genetic Polymorphism of Azathioprine Metabolizing Enzymes and Correlation to Clinical Adverse Effects

CompletedOBSERVATIONAL
Enrollment

166

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

January 31, 2008

Conditions
AzathioprineThiopurine MethyltransferaseInosine Triphosphate PyrophosphataseGenetic Polymorphism
Interventions
DRUG

Azathioprine

azathioprine usual dosage 100mg per day

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00525473 - Correlation of Genetic Polymorphism of Azathioprine Metabolizing Enzymes and Correlation to Clinical Adverse Effects | Biotech Hunter | Biotech Hunter